One of the directions of modern ophthalmology is toward an odontoiatric model, and new settings of eye care are becoming the standard of care: one day surgery and also office-based therapies.
Methods:
Retrospective analysis of three tertiary-care centers in Italy and analysis of the literature.
Results:
We provide readers with state-of-the-art measures of prophylaxis in ophthalmic surgery.
Discussion and conclusion:
Role of antibiotics is criticized in the light of stewardship antimicrobial paradigm.
EnglanderMChenTCPaschalisEIet al. Intravitreal injections at the Massachusetts Eye and Ear Infirmary: analysis of treatment indications and postinjection endophthalmitis rates. Br J Ophthalmol2013; 97: 460–465.
7.
KimSJChomskyASSternbergPJr.Reducing the risk of endophthalmitis after intravitreous injection. JAMA Ophthalmol2013; 131(5): 674–675.
8.
HsuJGerstenblithATGargSJet al. Conjunctival flora antibiotic resistance patterns after serial intravitreal injections without postinjection topical antibiotics. Am J Ophthalmol2014; 157: 514–518.
9.
GrossoA.A critical debate about the prophylaxis strategies in patients who undergo intravitreal injections is warranted. Retina2008; 28(10): 1556–1559.
10.
AlabiadCRMillerDSchiffmanJCet al. Antimicrobial resistance profiles of ocular and nasal flora in patients undergoing intravitreal injections. Am J Ophthalmol2011; 152(6): 999–1004.
11.
AbellRGKerrNMAllenPet al. Intravitreal injections: is there benefit for a theatre setting?Br J Ophthalmol2012; 96(12): 1474–1478.
12.
BrynskovTKempHSørensenTL.No cases of endophthalmitis after 20,293 intravitreal injections in an operating room setting. Retina2014; 34(5): 951–957.
13.
TabandehHBosciaFSborgiaAet al. Endophthalmitis associated with intravitreal injections: office-based setting and operating room setting. Retina2014; 34(1): 18–22.
14.
ParkeDW2ndColemanALRichWLet al. Choosing wisely: five ideas that physicians and patients can discuss. Ophthalmology2013; 120(3): 443–444.
15.
GrossoAPertileGMarchiniGet al. Adherence to European Society for Cataract and Refractive Surgery recommendations amongst Italian cataract surgeons: a survey. Eur J Ophthalmol2016; 26(5): 398–404.
16.
CaoHZhangLLiLet al. Risk factors for acute endophthalmitis following cataract surgery: a systematic review and meta-analysis. PLoS ONE2013; 8(8): e71731.
17.
Endophthalmitis Study Group European Society of Cataract Refractive Surgeons. Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors. J Cataract Refract Surg2007; 33(6): 978–988.
18.
BarryPCordovesLGradnerS.ESCRS guidelines for prevention and treatment of endophthalmitis following cataract surgery: data, dilemmas and conclusions2013, www.escrs.org (accessed July 2014).
19.
FayersTLohGKCordeiroMFet al. Overprescribing of antibiotics by UK ophthalmologists. Eye2018; 32(2): 240–242.
20.
MatsuuraKMoriTMiyamotoTet al. Survey of Japanese ophthalmic surgeons regarding perioperative disinfection and antibiotic prophylaxis in cataract surgery. Clin Ophthalmol2014; 8: 2013–2018.
21.
BeselgaDCamposACastroMet al. Postcataract surgery endophthalmitis after introduction of the ESCRS protocol: 5-year study. Eur J Ophthalmol2014; 24(4): 516–519.
22.
BarryP.Adoption of intracameral antibiotic prophylaxis of endophthalmitis following cataract surgery: update on the ESCRS Endophthalmitis Study. J Cataract Refract Surg2014; 40(1): 142–138.
23.
KamJKBuckDDawkinsRet al. Survey of prophylactic intracameral antibiotic use in cataract surgery in an Australian context. Clin Exp Ophthalmol2014; 42(4): 398–400.
24.
ScottIUFlynnHWJrDevSet al. Endophthalmitis after 25 gauge and 20 gauge pars plana vitrectomy: incidence and outcomes. Retina2008; 28(1): 138–142.
25.
RecchiaFMScottIUBrownGCet al.; Ophthalmic Technology Assessment Committee Retina Panel. Small gauge pars plana vitrectomy: a report by the American Academy of Ophthalmology. Ophthalmology2010; 117(9): 1851–1857.
26.
GovettoAVirgiliGMenchiniFet al. A systematic review of endophthalmitis after microincisional versus 20g vitrectomy. Ophthalmology2013; 120(11): 2286–2291.
27.
BahraniHMFazelatAAThomasMet al. Endophthalmitis in the era of small gauge transconjunctival sutureless vitrectomy—meta analysis and review of the literature. Semin Ophthalmol2010; 25(5–6): 275–282.
28.
KaiserRSPrennerJScottIUet al. The microsurgical safety task force: evolving guidelines for minimizing the risk of endophthalmitis associated with microincisional vitrectomy surgery. Retina2010; 30(4): 692–699.
29.
MeredithTAMcCannelCABarrCet al. Postinjection endophthalmitis in the comparison of age-related macular degeneration treatments trials (CATT). Ophthalmology2015; 122(4): 817–821.
30.
FigurskaM.[Azithromycin in prophylaxis of intravitreal injections in patients with wet age-related macular degeneration]. Klin Oczna2011; 113(1–3): 38–41 (in Polish).
31.
TominagaAOshimaYWakabayashiTet al. Bacterial contamination of the vitreous cavity associated with transconjunctival 25-gauge microincision vitrectomy surgery. Ophthalmology2010; 117(4): 811–817.
32.
ChenJKKhuranaRNNguyenQDet al. The incidence of endophthalmitis following transconjunctival sutureless 25- vs 20-gauge vitrectomy. Eye2009; 23(4): 780–784.
33.
ChangCJChangYHChianqSYet al. Comparison of transconjunctival sutureless vitrectomy and standard 20 gauge vitrecto my for patients with cataract and vitreoretinal diseases. J Cataract Refract Surg2005; 31: 1198–1207.
OshimaYOhjiMTanoY.Surgical outcomes of 25-gauge transconjunctival vitrectomy combined with cataract surgery for vitreoretinal diseases. Ann Acad Med Singapore2006; 35(3): 175–180.
36.
AyyalaRSBellowsARThomasJVet al. Bleb infections: clinically different courses of “blebitis” and endophthalmitis. Ophthalmic Surg Lasers1997; 28(6): 452–460.
CiullaTABeckADToppingTMet al. Blebitis, early endophthalmitis, and late endophthalmitis after glaucoma-filtering surgery. Ophthalmology1997; 104(6): 986–995.
39.
SongAScottIUFlynnHWJret al. Delayed-onset bleb-associated endophthalmitis: clinical features and visual acuity outcomes. Ophthalmology2002; 109(5): 985–991.
40.
JampelHDQuigleyHAKerrigan-BaumrindLAet al.; Glaucoma Surgical Outcomes Study Group. Risk factors for late-onset infection following glaucoma filtration surgery. Arch Ophthalmol2001; 119(7): 1001–1008.
41.
YassinSA.Bleb-related infection revisited: a literature review. Acta Ophthalmol2016; 94(2): 122–134.
42.
AngGSVargaZShaarawyT.Postoperative infection in penetrating versus non-penetrating glaucoma surgery. Br J Ophthalmol2010; 94(12): 1571–1576.
43.
MandalosASungV.Glaucoma drainage device surgery in children and adults: a comparative study of outcomes and complications. Graefes Arch Clin Exp Ophthalmol2017; 255: 1003–1011.
44.
Al-TorbakAAAl-ShahwanSAl-JadaanIet al. Endophthalmitis associated with the Ahmed glaucoma valve implant. Br J Ophthalmol2005; 89(4): 454–458.
45.
SidotiPABelmonteSJLiebmannJMet al. Trabeculectomy with mitomycin-C in the treatment of pediatric glaucomas. Ophthalmology2000; 107(3): 422–429.
Wallin Al-ahramyÖAMLundströmMMontanP.Endophthalmitis and severe blebitis following trabeculectomy. Epidemiology and risk factors: a single-centre retrospective study. Acta Ophthalmol2014; 92(5): 426–431.
48.
Brillat-ZaratzianEBronAAptelFet al. FRIENDS Group: clinical and microbiological characteristics of post-filtering surgery endophthalmitis. Graefes Arch Clin Exp Ophthalmol2014; 252(1): 101–107.
49.
MadyRJHollandBKBhagatNet al. Intraocular pressure outcomes after endophthalmitis associated with glaucoma surgery. J Glaucoma2015; 24(2): 122–126.
50.
AabergTMJrFlynnHWJrSchiffmanJet al. Nosocomial acute-onset postoperative endophthalmitis survey. A 10-year review of incidence and outcomes. Ophthalmology1998; 105(6): 1004–1010.
KattanHMFlynnHWJrPflugfelderSCet al. Nosocomial endophthalmitis survey. Current incidence of infection after intraocular surgery. Ophthalmology1991; 98(2): 227–238.
PoulsenEJAllinghamRR.Characteristics and risk factors of infections after glaucoma filtering surgery. J Glaucoma2000; 9(6): 438–443.
55.
MochizukiKJikiharaSAndoYet al. Incidence of delayed onset infection after trabeculectomy with adjunctive mitomycin C or 5-fluorouracil treatment. Br J Ophthalmol1997; 81(10): 877–883.
56.
AlwitryAKingAJ.Surveillance of late-onset bleb leak, blebitis and bleb-related endophthalmitis—a UK incidence study. Graefes Arch Clin Exp Ophthalmol2012; 250(8): 1231–1236.
57.
FreedmanJGuptaMBunkeA.Endophthalmitis after trabeculectomy. Arch Ophthalmol1978; 96(6): 1017–1018.
58.
KatzLJCantorLBSpaethGL.Complications of surgery in glaucoma. Early and late bacterial endophthalmitis following glaucoma filtering surgery. Ophthalmology1985; 92(7): 959–963.
59.
Collignon-BrachJ.[Surgery for glaucoma and endophthalmitis]. Bull Soc Belge Ophtalmol1996; 260: 73–77.
60.
WolnerBLiebmannJMSassaniJWet al. Late bleb-related endophthalmitis after trabeculectomy with adjunctive 5-fluorouracil. Ophthalmology1991; 98(7): 1053–1060.
61.
UchidaSSuzukiYAraieMet al. Long-term follow-up of initial 5-fluorouracil trabeculectomy in primary open-angle glaucoma in Japanese patients. J Glaucoma2001; 10(6): 458–465.
62.
GreenfieldDSSuñerIJMillerMPet al. Endophthalmitis after filtering surgery with mitomycin. Arch Ophthalmol1996; 114(8): 943–949.
63.
HigginbothamEJStevensRKMuschDCet al. Bleb-related endophthalmitis after trabeculectomy with mitomycin C. Ophthalmology1996; 103(4): 650–656.
64.
DeBryPWPerkinsTWHeatleyGet al. Incidence of late-onset bleb-related complications following trabeculectomy with mitomycin. Arch Ophthalmol2002; 120(3): 297–300.
65.
SharanSTropeGEChipmanMet al. Late-onset bleb infections: prevalence and risk factors. Can J Ophthalmol2009; 44(3): 279–283.
66.
YamamotoTSawadaAMayamaCet al.; Collaborative Bleb-Related Infection Incidence and Treatment Study Group. The 5-year incidence of bleb-related infection and its risk factors after filtering surgeries with adjunctive mitomycin C: collaborative bleb-related infection incidence and treatment study 2. Ophthalmology2014; 121(5): 1001–1006.
67.
KimEALawSKColemanALet al. Long-term bleb-related infections after trabeculectomy: incidence, risk factors, and influence of bleb revision. Am J Ophthalmol2015; 159(6): 1082–1091.
68.
ZahidSMuschDCNiziolLMet al.; Collaborative Initial Glaucoma Treatment Study Group. Risk of endophthalmitis and other long-term complications of trabeculectomy in the Collaborative Initial Glaucoma Treatment Study (CIGTS). Am J Ophthalmol2013; 155(4): 674–680.
69.
VaziriKKishorKSchwartzSGet al. Incidence of bleb-associated endophthalmitis in the United States. Clin Ophthalmol2015; 9: 317–322.
70.
SteinJDRuizDJrBelskyDet al. Longitudinal rates of postoperative adverse outcomes after glaucoma surgery among medicare beneficiaries 1994 to 2005. Ophthalmology2008; 115(7): 1109–1116.
71.
WentzloffJNGrosskreutzCLPasqualeLRet al. Endophthalmitis after glaucoma drainage implant surgery. Int Ophthalmol Clin2007; 47(2): 109–115.
72.
ZhengCXMosterMRKhanMAet al. Infectious endophthalmitis after glaucoma drainage implant surgery: clinical features, microbial spectrum, and outcomes. Retina2017; 37: 1160–1167.
73.
Al RashaedSArevaloFAl SulaimanSet al. Endophthalmitis trends and outcomes following glaucoma surgery at a Tertiary Eye Care Hospital in Saudi Arabia. J Glaucoma2016; 25(2): e70–e75.
74.
RoySMermoudA.[Complications of deep nonpenetrating sclerectomy]. J Fr Ophtalmol2006; 29(10): 1180–1197.
75.
Detry-MorelMDetryMB.Five-year experience with non penetrating deep sclerectomy. Bull Soc Belge Ophtalmol2006; (299): 83–94.
76.
AnandNAroraSClowesM.Mitomycin C augmented glaucoma surgery: evolution of filtering bleb avascularity, transconjunctival oozing, and leaks. Br J Ophthalmol2006; 90(2): 175–180.
77.
AnandNPillingR.Nd:YAG laser goniopuncture after deep sclerectomy: outcomes. Acta Ophthalmol2010; 88(1): 110–115.
78.
BissigARivierDZaninettiMet al. Ten years follow-up after deep sclerectomy with collagen implant. J Glaucoma2008; 17(8): 680–686.
79.
WishartPKWishartMSChoudharyAet al. Long-term results of viscocanalostomy in pseudoexfoliative and primary open angle glaucoma. Clin Exp Ophthalmol2008; 36(2): 148–155.
80.
MossJMSanisloSRTaCN.A prospective randomized evaluation of topical gatifloxacin on conjunctival flora in patients undergoing intravitreal injections. Ophthalmology2009; 116(8): 1498–1501.
81.
YinVTWeisbrodDJEngKTet al. Antibiotic resistance of ocular surface flora with repeated use of a topical antibiotic after intravitreal injection. JAMA Ophthalmol2013; 131(4): 456–461.
82.
DaveSBTomaHSKimSJ.Changes in ocular flora in eyes exposed to ophthalmic antibiotics. Ophthalmology2013; 120(5): 937–941.
83.
ZickJJoondephB.Is a postoperative day one examination needed after uncomplicated vitreoretinal surgery?Retina, 2018Feb; 38(2): 331–333.